Friday, March 1, 2024
10:00 AM - 12:00 PM010: Overactive Bladder (OAB) Bootcamp: Update on Current Treatment Approaches
1:45 PM - 3:15 PM101: Urological Considerations in the Management of the Gender-Diverse Patient Following Gender-Affirming Surgery
3:25 PM - 4:25 PM111: Urogenital Fistulas
3:25 PM - 4:25 PM112: Pharmacologic Management of Peyronie’s Disease and Ejaculatory Disorders Rx
4:30 PM - 6:30 PMExhibits / Opening Reception
Saturday, March 2, 2024
8:00 AM - 9:00 AM201: Training the Advanced Practice Provider in Urology
9:00 AM - 10:45 AMExhibits Open / Continental Breakfast
10:50 AM - 11:50 AM202: Nocturia
11:55 AM - 12:55 PM203: Value-Based Care in Urology/Urogynecology
1:00 PM - 2:15 PM210: DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment - Sponsored by Sumitomo Pharma America, Inc.
2:20 PM - 3:20 PM220: Screening Guidelines for Early Detection of Prostate Cancer
3:30 PM - 4:30 PM230: Multidisciplinary and Trauma-Informed Care Strategies for Interstitial Cystitis and Pelvic Pain
4:35 PM - 5:35 PM240: Sonographic Evaluation of the Pelvic Floor
Sunday, March 3, 2024
7:00 AM - 8:15 AM301:A Treatment Approach for Certain Patients With High-risk, Non-muscle Invasive Bladder Cancer by Merck
8:25 AM - 9:25 AM302: Why Federal Advocacy Matters for the Nursing Profession
9:35 AM - 10:35 AM311: Anabolic Steroid-Induced Hypogonadism
9:35 AM - 10:35 AM312: Pessaries
10:45 AM - 11:45 AM320: Telehealth – Post-Pandemic
11:45 AM - 1:00 PM330: Product Theater Lunch Sponsored by Novo Nordisk
1:00 PM - 2:00 PM340: Navigating the AI Landscape: Essential Applications for Advanced Practice Nursing
2:10 PM - 3:10 PM350: Bridging the Healthcare Divide: APPs at the Forefront of Expanding Access to Quality Care Nationwide